Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up - Ugurel, Selma; Utikal, Jochen; Helmbold, Peter; Leverkus, Martin; Schadendorf, Dirk (Clinical cancer research, 2014)
Gesehen am 01.08.2014